Login to Your Account

Grass allergy tabs recommended by FDA committee

By Catherine Shaffer
Staff Writer

Wednesday, December 11, 2013
The FDA’s Allergenic Products Advisory Committee will issue a recommendation on Stallergenes SA’s Oralair grass allergy tablet, a therapy that’s well established in Europe, for first-time approval in the U.S. market.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription